See every side of every news story

Published 3 days ago • loading... • Updated 3 days ago

TELA Bio Pulls 2026 Outlook as Sales Fall, Loss Widens

Summary by MyChesCo

MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) withdrew its full-year 2026 revenue guidance after second-quarter sales fell 4% and its net loss widened, with newly appointed Chief Executive Officer …

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

1 Articles

TELA Bio Pulls 2026 Outlook as Sales Fall, Loss Widens

MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) withdrew its full-year 2026 revenue guidance after second-quarter sales fell 4% and its net loss widened, with newly appointed Chief Executive Officer …

3 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated3 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MyChesCo broke the news 3 days ago on Monday, August 17, 2026.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics